Tenax Therapeutics, Inc.
NASDAQ:TENXBiotechnology
+$0.10 today
- Market cap
- $50.66M
- Beta
- 0.97
- P/E (TTM)
- -9.4
- EPS (TTM)
- -$1.28
Volume 0.70M
Average 0.62M
TENX Total Debt
Short-term and long-term borrowings combined.
Tenax Therapeutics, Inc.NASDAQ: TENX
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt remains negative
Q1 FY2026 total debt was $0, compared with $0 a year earlier.
Context
- Total debt amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Total debt increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | -100.0% |
| FY2023 | 2023-12-31 | 500.9K | -38.0% |
| FY2022 | 2022-12-31 | 807.89K | +177.8% |
| FY2021 | 2021-12-31 | 290.78K | — |
Total Debt vs competitors
How TENX compares with its peers on the latest reported figures
- TENX's Mar 2026 total debt of $0 is the 6th highest of the 7 companies compared; the peer median is $8.06M.
- Total debt amounts to 0.0% of total assets for TENX, versus a peer median of 2.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $71.74M | — | — | 0.1% | |
| Mar 2026 | $48.29M | -0.6% | +111.5% | 34.3% | |
| Mar 2026 | $10.99M | -41.5% | -30.0% | 17.3% | |
| Jun 2026 | $5.13M | -20.0% | +0.1% | 2.2% | |
| Mar 2026 | $1.44M | -96.6% | +2.2% | 3.7% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding TENX) | $8.06M | -30.8% | +1.2% | 2.9% | |
Competitors are the stored peer set for TENX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Tenax Therapeutics, Inc.
NASDAQ:TENX
Intrinsic Alpha fair value
Locked
Current Price
$1.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.